- ►duanesolution.com JÉ Ruiz-Moreno, JA MONTERO, S Barile, MA … - Retina, 2006 - journals.lww.com Purpose: To evaluate the efficacy of photodynamic therapy with verteporfin (PDT)
and high-dose intravitreous triamcinolone acetonide to treat choroidal new
vessels (CNVs) associated with age-related macular degeneration (AMD). ... Cited by 45 - Related articles - BL Direct - All 8 versions
B Dasch, A Fuhs, T Behrens, A Meister, J … - Archives of Ophthalmology, 2005 - archopht.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 21 - Related articles - BL Direct - All 4 versions
PC Lo, SCH Leung, EYM Chan, WP Fong, WH … - Photodiagnosis and Photodynamic Therapy, 2007 - Elsevier The photodynamic activities of a novel series of silicon(IV) phthalocyanines
with different axial substituents including the 1,3-bis(dimethylamino)-2-propoxy
group, isopropylidene-protected galactose, and polyethylene glycol have ... Cited by 8 - Related articles - All 6 versions
- ►iovs.org M Berdugo, RA Bejjani, F Valamanesh, M … - Investigative Ophthalmology & Visual Science, 2008 - ARVO RESULTS. When occlusive parameters (fluence of 50 J/cm 2 , 5 mg/kg drug dose and
DLI [distance to light illumination] of 1 minute) were used, Stakel PDT was
efficient immediately after treatment without associated structural damage ... Cited by 5 - Related articles - BL Direct - All 6 versions
R Hahn, S Sacu, S Michels, A Varga, G Weigert … - Der Ophthalmologe, 2007 - Springer Der Beitrag wurde auf der 104. Jahrestagung der Deutschen Ophthalmologischen
Gesell- schaft im Jahr 2006 in Berlin vorgetragen. ... Ophthalmologe 2007 ·
104:588–593 DOI 10.1007/s00347-007-1547-4 Online publiziert: 13. Juni ... Cited by 4 - Related articles - BL Direct - All 2 versions
JD Hirsch, C Morello, R Singh, SL Robbins - Survey of Ophthalmology, 2007 - Elsevier There is increasing pressure for medical care reimbursement to be linked to
outcomes. New medications approved for glaucoma, age-related macular
degeneration (AMD), and dry eye disease may offer improved outcomes, but ... Cited by 2 - Related articles - All 2 versions
AF Cruess, G Zlateva, AM Pleil, B Wirostko - Acta Ophthalmologica, 2009 - interscience.wiley.com Photodynamic therapy (PDT) with verteporfin has been used less comprehensively
in the treatment of exudative age-related macular degeneration (AMD), and
specifically of choroidal neovascularization (CNV), since the advent of ... Cited by 3 - Related articles - All 3 versions
F Behar-Cohen, F Sennlaub, M Berdugo - Med Sci (Paris), 2007 - edk.fr > La dégénérescence maculaire liée à l'âge (DMLA) est la cause la plus
fré- quente de cécité non curable dans les pays industrialisés, avec une
prévalence de 0,05% avant l'âge de 50 ans et de 11,8 % après 80 ans. On ... Cited by 3 - Related articles - View as HTML - All 8 versions
JC Javitt, GP Zlateva, SR Earnshaw, AM … - Value in Health, 2008 - prsjournal.com Methods: A Markov framework was used to model lifetime movement of a subfoveal
NV-AMD cohort through health states based on visual acuity. The model takes a US
payer perspective of patients over the age of 65 years. Clinical efficacy ... Cited by 1 - Related articles - Cached - All 5 versions
